Cipla
Suhas Patil possesses over 15 years of comprehensive experience in chemical engineering processes and operations management, currently serving as Manager of API Technology Transfer at Cipla since January 2019. Previously held the position of Deputy Manager of API Technology Transfer at Cipla Ltd in Kurkumbh, Pune, from July 2007 to July 2022. Suhas has extensive expertise in API technology transfer, API manufacturing processes, cGMP documentation, and the commissioning of API bulk drug projects, alongside a strong focus on operational and manufacturing excellence. Suhas Patil obtained a Bachelor of Engineering in Chemical Engineering from Shivaji University, completing the degree between 2002 and 2007.
This person is not in any teams
This person is not in any offices
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.